drugset / Trial / NCT02951715

Improvement of Tinnitus After Oral Zinc on Patients With Noise-induced Hearing Loss

NCT02951715

NaSingle-groupOpen-labelTreatment

Summary

Twenty patients with tinnitus and a typical noise-induced hearing loss (NIHL) audiogram were included. Each subject underwent an otoscopic examination, distortion product otoacoustic emissions, tinnitus-match testing, Tinnitus Handicap Inventory (THI) and serum zinc level analyses. After 2 months of treatment with zinc, all tests were repeated.

Timeline

Start
2013-12
Primary completion
2014-12
Completion
2014-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Zinc gluconate Small molecule 40 mg